| Literature DB >> 25807462 |
Pilar Sepúlveda-Varas1, Daniel M Weary2, Mirela Noro3, Marina A G von Keyserlingk2.
Abstract
The objectives of this study were to describe the incidence of postpartum disease and to evaluate the association with serum cholesterol concentrations during the first 3 weeks after calving in grazing dairy cows. The association between non-esterified fatty acids (NEFA), β-hydroxybutyrate (BHBA), calcium and postpartum diseases was also evaluated. A total of 307 Holstein dairy cows from 6 commercial grazing herds in Osorno, Chile, were monitored from calving until 21 days in milk. Cases of retained placenta, clinical hypocalcemia and clinical mastitis were recorded by the farmer using established definitions. Twice weekly, cows were evaluated for metritis by the same veterinarian based on vaginal discharge and body temperature. Postpartum blood samples were collected weekly and analyzed for serum concentrations of cholesterol, NEFA, BHBA and calcium. Cows were considered as having subclinical ketosis if BHBA >1.2 mmol/L, and subclinical hypocalcemia if calcium <2.0 mmol/L in any of the 3 weekly samples. Overall, 56% of the cows studied developed at least one clinical or subclinical disease after calving. Incidence of individual diseases was 8.8% for retained placenta, 4.2% for clinical hypocalcemia, 11.7% for clinical mastitis, 41.1% for metritis, 19.9% for subclinical hypocalcemia and 16.6% for subclinical ketosis. Lower postpartum cholesterol in cows was associated with developing severe metritis or having more than one clinical disease after calving. For every 0.4 mmol/L decrease in serum cholesterol cows were nearly twice as likely to be diagnosed with multiple clinical diseases after calving. Higher BHBA concentrations and lower calcium concentrations during week 1 were associated with severe cases of metritis. Low serum calcium concentration during week 1 was also associated with developing more than one clinical disorder after calving. In conclusion, the incidence of postpartum diseases can be high even in grazing herds and lower serum cholesterol concentrations were associated with occurrence of clinical postpatum disorders.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25807462 PMCID: PMC4373813 DOI: 10.1371/journal.pone.0122317
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Incidence of clinical and subclinical events during the first 21 DIM by farm (A, n = 63; B, n = 53; C, n = 59; D, n = 53; E, n = 49; F, n = 30) and parity [primiparous (PP), n = 57; multiparous (MP), n = 250], including overall incidence (n = 307).
| Disease and health status | Overall | Farm | Parity | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. | % | A | B | C | D | E | F | PP | MP | |
| Clinical diseases | ||||||||||
| Type of disease | ||||||||||
| Retained placenta | 27 | 8.8 | 12.7 | 13.2 | 5.1 | 0 | 14.3 | 6.7 | 2.0 | 6.8 |
| Clinical hypocalcemia | 13 | 4.2 | 7.9 | 7.6 | 1.7 | 0 | 2.0 | 6.7 | 0.3 | 3.9 |
| Clinical mastitis | 36 | 11.7 | 19.1 | 13.2 | 10.2 | 0 | 14.3 | 13.3 | 3.3 | 8.5 |
| Mild metritis | 73 | 23.8 | 22.2 | 39.6 | 27.1 | 9.4 | 22.5 | 20,0 | 7.5 | 16.3 |
| Severe metritis | 53 | 17.3 | 15.9 | 17.0 | 15.3 | 10.2 | 20.4 | 26.1 | 3.9 | 13.4 |
| Health status | ||||||||||
| No event | 167 | 54.4 | 54 | 39.6 | 54.2 | 77.4 | 49 | 50 | 35.1 | 58.8 |
| One event | 93 | 30.3 | 27 | 39.6 | 33.9 | 22.6 | 30.6 | 26.7 | 42.1 | 27.6 |
| Multiple events | 47 | 15.3 | 19 | 20.8 | 11.9 | 0 | 20.4 | 23.3 | 22.8 | 13.6 |
| Subclinical diseases | ||||||||||
| Type of disease | ||||||||||
| Hypocalcemia | 61 | 19.9 | 31.8 | 24.5 | 20.3 | 9.4 | 12.2 | 16.7 | 4.2 | 15.6 |
| Ketosis | 51 | 16.6 | 7.9 | 26.4 | 25.4 | 11.3 | 14.3 | 13.3 | 3.6 | 13.0 |
| Health status | ||||||||||
| No event | 209 | 68.1 | 63.5 | 58.5 | 59.3 | 84.9 | 73.5 | 73.5 | 63.2 | 69.2 |
| One event | 84 | 27.4 | 33.5 | 32.1 | 35.6 | 9.9 | 26.5 | 23.5 | 31.6 | 26.4 |
| Multiple events | 14 | 4.5 | 3.1 | 9.4 | 5.1 | 5.6 | 0 | 3.3 | 5.3 | 4.4 |
| Clinical and subclinical | ||||||||||
| Health status | ||||||||||
| No event | 135 | 44.0 | 34.9 | 30.2 | 40.7 | 69.8 | 44.9 | 46.7 | 21.0 | 49.2 |
| One event | 76 | 24.8 | 33.3 | 30.2 | 22 | 18.8 | 18.4 | 23.3 | 40.4 | 21.2 |
| Multiple events | 96 | 31.3 | 31.8 | 39.6 | 37.3 | 11.4 | 36.7 | 30.0 | 38.6 | 29.6 |
Least squares mean (±SE) serum NEFA, BHBA, cholesterol and calcium concentrations in grazing cows relative to health outcome during the first 3 wk after calving.
| Analyte and health outcome | Period relative to calving | |||
|---|---|---|---|---|
| n | wk 1 | wk 2 | wk 3 | |
| NEFA (mmol/L) | ||||
| No event | 153 | 0.60 ± 0.05 | 0.59 ± 0.06 | 0.46 ± 0.10 |
| Clinical mastitis | 14 | 0.68 ± 0.10 | 0.69 ± 0.10 | 0.49 ± 0.12 |
| Mild metritis | 54 | 0.58 ± 0.06 | 0.57 ± 0.08 | 0.42 ± 0.10 |
| Severe metritis | 22 | 0.76 ± 0.09 | 0.70 ± 0.10 | 0.51 ± 0.10 |
| Multiple events | 45 | 0.70 ± 0.06 | 0.58 ± 0.08 | 0.49 ± 0.12 |
| BHBA (mmol/L) | ||||
| No event | 153 | 0.65 ± 0.04 | 0.72 ± 0.04 | 0.66 ± 0.04 |
| Clinical mastitis | 14 | 0.64 ± 0.09 | 0.73 ± 0.09 | 0.68 ± 0.04 |
| Mild metritis | 54 | 0.73 ± 0.05 | 0.73 ± 0.06 | 0.65 ± 0.05 |
| Severe metritis | 20 | 0.96 ± 0.08 | 0.88 ± 0.08 | 0.60 ± 0.05 |
| Multiple events | 45 | 0.74 ± 0.05 | 0.74 ± 0.06 | 0.64 ± 0.05 |
| Cholesterol (mmol/L) | ||||
| No event | 153 | 2.15 ± 0.17 | 2.70 ± 0.20 | 3.18 ± 0.20 |
| Clinical mastitis | 14 | 2.20 ± 0.20 | 2.39 ± 0.20 | 3.12 ± 0.20 |
| Mild metritis | 54 | 2.21 ± 0.18 | 2.42 ± 0.20 | 2.96 ± 0.20 |
| Severe metritis | 20 | 2.29 ± 0.20 | 2.18 ± 0.20 | 2.83 ± 0.20 |
| Multiple events | 45 | 1.94 ± 0.18 | 2.25 ± 0.20 | 2.81 ± 0.20 |
| Calcium (mmol/L) | ||||
| No event | 153 | 2.29 ± 0.04 | 2.34 ± 0.04 | 2.38 ± 0.04 |
| Clinical mastitis | 14 | 2.28 ± 0.08 | 2.22 ± 0.06 | 2.29 ± 0.06 |
| Mild metritis | 54 | 2.26 ± 0.06 | 2.34 ± 0.04 | 2.38 ± 0.04 |
| Severe metritis | 20 | 2.17 ± 0.08 | 2.26 ± 0.06 | 2.38 ± 0.06 |
| Multiple events | 45 | 2.08 ± 0.06 | 2.30 ± 0.05 | 2.36 ± 0.04 |
a No event = cows that did not develop any clinical disorder of interest (retained placenta, clinical hypocalcemia, clinical mastitis, mild or severe metritis) by 22 DIM.
b Multiple events = cows that developed 2 or more clinical disorders (retained placenta, clinical hypocalcemia, clinical mastitis, mild or severe metritis) by 22 DIM.
†P ≤ 0.1
*P ≤ 0.05
**P ≤ 0.01
***P ≤ 0.001 indicate differences in these analytes between No event cows and cows with one event (clinical mastitis, mild metritis or severe metritis only), and between No event cows and cows with Multiple events.
Logistic regression models describing the association between serum NEFA, BHBA, cholesterol and calcium in grazing cows and the risk for the health outcomes of interest: (1) severe metritis versus no event, and (2) multiple events versus no event during the first 3 wk after calving.
| Period relative to calving and health outcome | Analyte | OR | 95% CI |
|
|---|---|---|---|---|
| wk 1 | ||||
| Severe metritis | NEFA | 1.00 | 1.00–1.01 | 0.122 |
| BHBA | 1.95 | 1.32–2.90 | 0.001 | |
| Cholesterol | 0.85 | 0.67–1.08 | 0.199 | |
| Calcium | 1.40 | 0.99–1.99 | 0.060 | |
| Multiple events | NEFA | 1.00 | 1.00–1.01 | 0.002 |
| BHBA | 1.12 | 0.78–1.61 | 0.514 | |
| Cholesterol | 1.54 | 1.16–2.04 | 0.006 | |
| Calcium | 1.83 | 1.39–2.40 | <0.001 | |
| wk 2 | ||||
| Severe metritis | NEFA | 1.00 | 1.00–1.00 | 0.374 |
| BHBA | 1.34 | 0.98–1.83 | 0.063 | |
| Cholesterol | 1.69 | 1.20–2.36 | 0.002 | |
| Calcium | 1.23 | 0.85–1.79 | 0.266 | |
| Multiple events | NEFA | 1.00 | 1.00–1.00 | 0.220 |
| BHBA | 1.03 | 0.79–1.33 | 0.805 | |
| Cholesterol | 1.81 | 1.40–2.38 | <0.001 | |
| Calcium | 1.20 | 0.90–1.58 | 0.196 | |
| wk 3 | ||||
| Severe metritis | NEFA | 1.00 | 1.00–1.00 | 0.901 |
| BHBA | 0.85 | 0.53–1.37 | 0.535 | |
| Cholesterol | 1.22 | 0.95–1.54 | 0.100 | |
| Calcium | 0.91 | 0.62–1.32 | 0.632 | |
| Multiple events | NEFA | 1.00 | 1.00–1.00 | 0.226 |
| BHBA | 1.57 | 0.98–2.52 | 0.606 | |
| Cholesterol | 1.44 | 1.17–1.77 | 0.008 | |
| Calcium | 1.18 | 0.86–1.60 | 0.287 | |
aAdjusted odds ratio per 0.1 unit increase in NEFA (mmol/L), per 0.3 unit increase in BHBA (mmol/L), 0.4 unit decrease in cholesterol (mmol/L), and per 0.2 unit decrease in calcium (mmol/L).